Cna Financial Corp Ptc Therapeutics, Inc. Transaction History

Cna Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$37.95 - $49.37 $386,710 - $503,080	-10,190 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$46.8 - $68.92 $20,592 - $30,324	-440 Reduced 4.14%	10,190 $482,000
Q4 2020 Feb 12, 2021	BUY	$47.96 - $67.64 $11,510 - $16,233	240 Added 2.31%	10,630 $649,000
Q3 2020 Nov 12, 2020	BUY	$45.41 - $57.07 $42,231 - $53,075	930 Added 9.83%	10,390 $486,000
Q2 2020 Aug 13, 2020	BUY	$42.56 - $54.98 $402,617 - $520,110	9,460 New	9,460 $480,000

221

78M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.14B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.